AMRN

#3389
Amarin Corp Plc
13.9500 USD
-0.07%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
13.4000
13.9900
Rango anual
13.4000
17.0000
Cambio diario
-0.07%
Variación mensual
-3.46%
Variación en los últimos 6 meses
-10.35%
Cambio anual
-10.35%
Cierres anteriores
13.9600
Abrir
13.4000
Mínimo
13.4000
High
13.9900
Volumen
49
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 290.2152 M
  • Employee 80
  • Founded 1989
  • CEO N/A
  • Website www.amarincorp.com
  • Headquarter United Kingdom
  • FIGI BBG000BPYG99
  • Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-155.06
Relación precio/flujo de caja
27.11

Amarin Corporation plc - American Depositary Shares, each repre

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza.

Noticias